GIP
CELG

Greatmark Investment Partners’s Celgene Corp CELG Stock Holding History

Greatmark Investment Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,000
Closed -$298K – 138
2019
Q3 		$298K Sell
3,000
-850
-22% -$80.8K 0.08% 100
2019
Q2 		$356K Sell
3,850
-325
-8% -$30.9K 0.11% 90
2019
Q1 		$394K Buy
4,175
+325
+8% +$28.4K 0.12% 84
2018
Q4 		$247K Buy
+3,850
New +$284K 0.09% 103

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Greatmark Investment Partners's CELG Position: Q4 2019 in Review

Greatmark Investment Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,000 shares — an estimated $298K sold.

Greatmark Investment Partners first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $394K in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Greatmark Investment Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Greatmark Investment Partners sold 3,000 Celgene Corp shares in Q4 2019, an estimated $298K.
  • Greatmark Investment Partners first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Greatmark Investment Partners's Celgene Corp position peaked at $394K in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Greatmark Investment Partners's 13F filing for Q4 2019, filed 31 Jan 2020.